Literature DB >> 20442677

An immunohistochemical study on the distribution and frequency of T regulatory cells in pancreatic islets of NOD mice during various stages of spontaneous and cyclophosphamide-accelerated diabetes.

Sarbjot Kaur1, Wan Ling Tan, Camelia Soo, Carlos Chun Ho Cheung, Joanna Stewart, Shiva Reddy.   

Abstract

OBJECTIVES: To determine if there is an abrupt change in the frequency of intraislet T regulatory (Treg) cells in female nonobese diabetic (NOD) mice preceding and following spontaneous diabetes and during cyclophosphamide-accelerated disease.
METHODS: The frequency of intraislet CD4-positive Treg cells was analyzed between days 21 and 250, at onset, and at 1, 2, and 3 weeks of diabetes by dual-label immunohistochemistry. Tissues were also analyzed between days 0 and 14 after injection of cyclophosphamide or diluent.
RESULTS: In the spontaneous group, intraislet Treg cells were first observed on day 30 in CD4 T cells and increased from day 45. There was no statistical difference in the frequency of Treg cells in nondiabetic NOD mice on days 45, 60, and 90. A sustained frequency at and after 1, 2, and 3 weeks of diabetes was also observed. In the cyclophosphamide group, there was a sharp decline in the frequency of Treg cells on day 4, which remained lower on day 7 but increased by days 11 and 14.
CONCLUSIONS: During spontaneous diabetes and after onset, the frequency of intraislet CD4-positive Treg cells remains unchanged. They may possess diminished immunoregulatory function and thus unable to counteract the increasing tempo of immune-mediated beta-cell destruction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20442677     DOI: 10.1097/MPA.0b013e3181da9037

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  3 in total

1.  Oral therapy for type 1 diabetes mellitus using a novel immunomodulator, FTY720 (fingolimod), in combination with sitagliptin, a dipeptidyl peptidase-4 inhibitor, examined in non-obese diabetic mice.

Authors:  Takumi Tsuji; Yuya Yoshida; Tetsuro Fujita; Takeyuki Kohno
Journal:  J Diabetes Investig       Date:  2012-10-18       Impact factor: 4.232

2.  Difficult-to-diagnose diabetes in a patient treated with cyclophosphamide - the contradictory roles of immunosuppressant agents: a case report.

Authors:  Manuel García-Sáenz; Daniel Uribe-Cortés; Claudia Ramírez-Rentería; Aldo Ferreira-Hermosillo
Journal:  J Med Case Rep       Date:  2018-12-10

3.  Expression profiling pre-diabetic mice to uncover drugs with clinical application to type 1 diabetes.

Authors:  Dimeng Pang; Katharine M Irvine; Ahmed M Mehdi; Helen E Thomas; Mark Harris; Emma E Hamilton-Williams; Ranjeny Thomas
Journal:  Clin Transl Immunology       Date:  2015-08-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.